| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/26/2011 | WO2007001943A3 Prefoldin 4 in the treatment and diagnosis of cancer |
| 05/26/2011 | US20110126321 Recombinant dna for gene suppression |
| 05/26/2011 | US20110126306 Circular Nucleic Acid Vectors, and Methods for Making and Using the Same |
| 05/26/2011 | US20110126303 Modified Blood Clotting Factors And Methods Of Use |
| 05/26/2011 | US20110124716 Ultrasound-assisted gene transfer to salivary glands |
| 05/26/2011 | US20110124707 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell |
| 05/26/2011 | US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110123553 Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination |
| 05/26/2011 | US20110123548 Compositions and methods for the treatment and diagnosis of immune disorders |
| 05/26/2011 | US20110123540 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123535 Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival |
| 05/26/2011 | US20110123511 Method of Suppressing Gene Transcription Through Histone Lysine Methylation |
| 05/26/2011 | US20110123509 Fusion molecules of rationally-designed dna-binding proteins and effector domains |
| 05/26/2011 | US20110123483 Hmgb1 for cancer treatment |
| 05/26/2011 | US20110123446 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 05/26/2011 | DE102009054265A1 Producing a gene encoded molecule comprises feeding a nucleic acid comprising a gene encoding the molecule to the arthropod |
| 05/26/2011 | CA2781332A1 System for increasing gene expression and vector comprising the system |
| 05/25/2011 | EP2325321A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325236A1 Dendritic polymers with enhanced amplification and interior functionality |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2325193A2 Methods and compositions for therapeutic use of RNA interference |
| 05/25/2011 | EP2324856A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 05/25/2011 | EP2324852A1 Therapeutic or prophylactic agent for generalized pain syndrome |
| 05/25/2011 | EP2324846A1 Use of urease for inhibiting cancer cell growth |
| 05/25/2011 | EP2324839A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/25/2011 | EP2323648A2 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| 05/25/2011 | EP1499731B1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 05/25/2011 | EP1325112B1 Methods of isolating bipotent hepatic progenitor cells |
| 05/25/2011 | EP1183330B1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 05/25/2011 | CN1772897B Cell factor with several functions |
| 05/25/2011 | CN102076352A Fgf-9 and its use relating to blood vessels |
| 05/25/2011 | CN102076351A Pharmaceutical agent for promoting functional regeneration of damaged tissue |
| 05/25/2011 | CN102076350A Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 05/25/2011 | CN102076328A Micelles for intracellular delivery of therapeutic agents |
| 05/25/2011 | CN102071219A Improved AAV2 (Adeno-Associated Virus II) vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome) |
| 05/25/2011 | CN102071206A Adeno-associated virus capsid protein gene, corresponding protein and application of protein |
| 05/25/2011 | CN102071205A Specific antigen of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102071204A Deoxyribonucleic acid (DNA) aptamer for mycobacterium tuberculosis glycolipid antigen and application thereof |
| 05/25/2011 | CN102071202A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071201A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071200A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071199A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071198A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071197A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071196A SiRNA for inhibiting canine p53 gene expression and canine cell model of p53 gene silence |
| 05/25/2011 | CN102071192A Small interfering RNA used for curing psoriasis |
| 05/25/2011 | CN102071191A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071190A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102071189A Small interfering RNA for treating psoriasis |
| 05/25/2011 | CN102070712A VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
| 05/25/2011 | CN102070710A Specific GRA2a (Glycine Rich Antigen)-type antigenic protein of clonorchis sinensis and application thereof |
| 05/25/2011 | CN102070704A Entire gene sequence of severe fever with thrombocytopenia syndrome virus (SFTSV) and application |
| 05/25/2011 | CN101579315B Immunoliposome based on endostatin gene, preparation method and application thereof |
| 05/25/2011 | CN101497876B Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof |
| 05/25/2011 | CN101492719B Uses of CXorf41 gene |
| 05/25/2011 | CN101457252B Application of E2F8 gene |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/25/2011 | CN101100666B Human TCRVbeta7.1_H3F7 gene and its screening method and application |
| 05/24/2011 | US7947810 Kits for diagnosing a hypophosphatemic disorder |
| 05/24/2011 | US7947731 Administering an agent that enhances Cyclic AMP response element binding protein (CREB) pathway function, training the animal to improve performance in the cognitive task; for people with central nervous system disorders |
| 05/24/2011 | US7947660 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 05/24/2011 | US7947659 iRNA agents targeting VEGF |
| 05/24/2011 | US7947658 RNA interference for the treatment of gain-of-function disorders |
| 05/24/2011 | US7947498 Embryonic stem cells and neural progenitor cells derived therefrom |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947448 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 05/24/2011 | US7947291 Modified surface antigen |
| 05/24/2011 | CA2504663C Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases |
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2229631C Gene therapy using ovine adenoviral vectors |
| 05/19/2011 | WO2011060435A1 Compositions and methods for treating cancer and other diseases |
| 05/19/2011 | WO2011060079A1 Compositions and methods for wound treatment |
| 05/19/2011 | WO2011060040A1 Diagnostic and therapeutic applications of the u6 snrna |
| 05/19/2011 | WO2011059503A1 Cells, vectors, and methods for treating a viral infection |
| 05/19/2011 | WO2011059334A1 Use of newcastle disease virus-based vector for inducing an immune response in mammals |
| 05/19/2011 | WO2011057350A1 Antisense molecules and methods for treating pathologies |
| 05/19/2011 | WO2011019793A3 Individualized therapy of single gene disorders with genetically modified adult stem cells |
| 05/19/2011 | WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders |
| 05/19/2011 | WO2010110914A3 Mammalian genes involved in infection |
| 05/19/2011 | WO2010070380A3 Doc1 compositions and methods for treating cancer |
| 05/19/2011 | US20110118445 Inhibitor protein of the wnt signal pathway |
| 05/19/2011 | US20110118338 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 05/19/2011 | US20110118333 Use on Minicircle vectors for cardiac gene therapy |
| 05/19/2011 | US20110118194 Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory Diseases |
| 05/19/2011 | US20110118193 Treatment of liquid cancers |
| 05/19/2011 | US20110117654 Buffer solution for electroporation and a method comprising the use of the same |
| 05/19/2011 | US20110117646 Antisense modulation of c-reactive protein expression |
| 05/19/2011 | US20110117608 Double-stranded nucleic acid |
| 05/19/2011 | US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them |
| 05/19/2011 | US20110117183 Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors |
| 05/19/2011 | US20110117138 Charge-dynamic polymers and delivery of anionic compounds |
| 05/19/2011 | US20110117078 Methods for the Treatment of Cancers |